Genomembrane Co., Ltd. was established as a bio-tech venture company in April, 2002, by a group of scientists. GenoMembrane’s aims are to provide transporter-related products and services that will be useful in the development and design of novel drugs for clinical application.
With the progress of research on the function of transporters as drug carriers, it has become increasingly important to take account of their effects at an early stage during drug development in order to minimize the costs associated with unsuccessful drugs.
GenoMembrane also provides research tools and collabrates for the pharmacological evaluation of drug candidates to minimize costs, help improve the success rate of candidate drugs, and speed up new drug development.
* GenoMembrane distributes our new products information including the latest news to customers who are interested in our products by e-mail.
Anyone with an e-mail address can subscribe to the service for free of charge.
If you have any questions or want to subscribe our mail news, please send a message to email@example.com.
GenoMembrane will only collect your personal information by appropriate and fair means and will not use your personal information beyond the scope of the purpose of use.